Anterior chamber associated immune deviation used as a neuroprotective strategy in rats with spinal cord injury

Abstract

The inflammatory response is probably one of the main destructive events occurring after spinal cord injury (SCI). Its progression depends mostly on the autoimmune response developed against neural constituents. Therefore, modulation or inhibition of this self-reactive reaction could help to reduce tissue destruction. Anterior chamber associated immune deviation (ACAID) is a phenomenon that induces immune-tolerance to antigens injected into the eye´s anterior chamber, provoking the reduction of such immune response. In the light of this notion, induction of ACAID to neural constituents could be used as a potential prophylactic therapy to promote neuroprotection. In order to evaluate this approach, three experiments were performed. In the first one, the capability to induce ACAID of the spinal cord extract (SCE) and the myelin basic protein (MBP) was evaluated. Using the delayed type hypersensibility assay (DTH) we demonstrated that both, SCE and MBP were capable of inducing ACAID. In the second experiment we evaluated the effect of SCE-induced ACAID on neurological and morphological recovery after SCI. In the results, there was a significant improvement of motor recovery, nociceptive hypersensitivity and motoneuron survival in rats with SCE-induced ACAID. Moreover, ACAID also up-regulated the expression of genes encoding for anti-inflammatory cytokines and FoxP3 but down-regulated those for pro-inflamatory cytokines. Finally, in the third experiment, the effect of a more simple and practical strategy was evaluated: MBP-induced ACAID, we also found significant neurological and morphological outcomes. In the present study we demonstrate that the induction of ACAID against neural antigens in rats, promotes neuroprotection after SCI.

Probiotics and Prebiotics as a Therapeutic Strategy to Improve Memory in a Model of Middle-Aged Rats

“…BDNF enhances and maintains LTP induction, therefore it plays an important role in cognitive function (Pang and Lu, 2004). Aging is characterized by a decrease in BDNF concentrations, which suggests that the retrieval of BDNF levels could have a significant impact on the salvage of cognitive impairment (Pineda-Rodriguez et al, 2017).…”

Interplay of Good Bacteria and Central Nervous System: Cognitive Aspects and Mechanistic Considerations

“…The level of BDNF has been found to be diminished in brain and serum of people with SCZ, AD, and anxiety ( Carlino et al, 2013 ; Lu et al, 2013 ; Mitew et al, 2013 ). Aging is also characterized by decreased concentration of BDNF, suggesting that the salvage of the BDNF could significantly underlies the retrieve of cognitive impairment ( Pineda-Rodriguez et al, 2017 ). It has been shown that the memory improving effect of probiotics accompany increased level of BDNF in the hippocampus ( O’Sullivan et al, 2011 ; Corpuz et al, 2018 ).…”

Neuroprotective Potential of Non-Digestible Oligosaccharides: An Overview of Experimental Evidence

“…Thus, aging is associated with reducing levels of BDNF. The maintenance of sufficient BDNF concentrations is suggested to delay the onset of cognitive impairments ( Pineda-Rodriguez et al, 2017 ). Several studies have highlighted the role of prebiotics and their metabolites (SCFA) in psychophysiological modulation via BDNF ( Sarkar et al, 2016 ; Park et al, 2017 ; Haghighat et al, 2019 ; Heyck and Ibarra, 2019 ).…”